Download full-text PDF |
Source |
---|
J Pharmacol Pharmacother
December 2013
Rheumatology Research Unit, Department of Medical and Surgical Sciences, Catanzaro, Italy.
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting about 6-10% of patients with cutaneous psoriasis. According to current knowledge, activated T-cells seem to play a pivotal role in the pathogenesis of both psoriasis and PsA. Abatacept is a novel biologic agent selectively designed to interfere with T-cells co-stimulation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!